News

The grant work will study adipose-derived regenerative cells in preclinical vascular disease models. This will involve looking into which cells within adipose tissue are optimal for remodeling and

Dr Francois Nader, executive vice president and COO, said: “We greatly appreciate the FDA’s support of our efforts to evaluate the use of Preos as a hormone replacement

The data was taken from the first cohort of volunteers in a phase I/II clinical trial sponsored by the Naval Medical Research Center (NMRC) and the US Military

This effect in a mouse model was seen within 14 days, most pronounced with a single dose of CEL-1000 at day 0 and resulted in up to a

In preclinical studies, REP3123 was superior to two agents widely used to treat C. difficile infections, vancomycin and metronidazole, in preventing the organism from forming spores. The study

Hi-Tech’s ciclopirox topical solution is the generic equivalent of Dermik Laboratories’ nail fungus treatment penlac topical solution, which had sales of $87 million in 2006 based on IMS

Under the terms of the agreement, Adams will receive an exclusive, royalty- bearing license from Lipocine to develop and market multiple prescription adult cough products in North America.

The Phase II, double-blind, placebo-controlled, multi-center trial includes 124 menopausal women with recurrent, moderate to severe hot flashes and is being conducted at eight sites in the US.

Preliminary findings from a Phase II study with intramuscular (im) injection of peramivir, the company’s product candidate for the treatment of seasonal and life-threatening influenza, found that the